Osteotech girds for rumble with dissident investors (MassDevice)
Osteotech Disputes Dissident Stockholders' Frivolous and Redundant Initiatives (Osteotech Press Release)
Unhappy Investors cite:
poor performance and 28% stock loss under CEO Sam Owusa-Akyaw
$4M loss in 2009
passed up on 2005 acquisition offer from MTF
loss a major private-label contract with Smith & Nephew
...
Your friends are reading OrthoStreams daily - Are you ?
Unlock your access to full rich article, trends, hot startups, market reports and your daily newsletter.
The Orthopedics Industry 
